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The Need to Improve the
Appropriate Use of Coronary
Revascularization
Challenges and Opportunities*
John Spertus, MD, MPH, Paul Chan, MD, MSC
Kansas City, Missouri
We stand at the precipice of extraordinary changes in
medicine. Prior generations of physicians sought to apply
any and all treatments available to preserve the health and
functioning of patients, despite incomplete knowledge of
disease processes and the evidence base to know the efficacy
of alternative treatment strategies. Over the past 4 decades,
an explosion of technology and treatments, with varying
degrees of clinical evidence to support or refute their value,
have been introduced. Congruent with these changes has
emerged an unsustainable explosion in the costs of care,
such that the economic future of the entire nation seems to
be held hostage to “bending the cost curve” and creating a
more sustainable model of lowering costs and maximizing
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the value of healthcare. Professional leadership in defining
how best to direct therapy to those who most benefit, while
withholding it in those with little to benefit (or are harmed),
is the most promising way to maximize the value of
healthcare—preserving the benefits of medical progress
while limiting costs (1,2). Toward that end, the recently
updated Manual of Medical Ethics by the American Col-
lege of Physicians explicitly states that “physicians have a
responsibility to practice effective and efficient health care
and to use health care resources responsibly . . . to help
ensure that resources are equitably available” (3).
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in the United States.Against this backdrop, the American College of Cardi-
ology (ACC) tackled a challenge confronting the entire
house of medicine by investing in a formal, critical evalua-
tion of the appropriateness of its procedures (4). In contrast
to the guidelines (5)—which synthesize the published data
to suggest what we “can do” in caring for patients—or
performance measures (6,7)—which distill the guidelines
into a set of discrete actions that we “must do” for our
patients—the appropriate use criteria (AUC) integrate the
guidelines, clinical trial evidence, and clinician experience to
quantify what we “should do.” By systematically evaluating
common clinical scenarios, the AUC define the strength of
the indications for a procedure, weighing both its benefits
and harms. In so doing, the ACC exhibited phenomenal
professional leadership in laying a foundation for evidence-
based, clinically informed assessments of procedural appro-
priateness so that any financial rationing of treatments could
be restricted to those with the least potential to benefit, as
opposed to draconian administrative decisions or rationing
through the time-consuming logistical hassles of navigat-
ing radiology benefits management companies. Raising
fears of the latter option, the Centers for Medicare and
Medicaid Services has recently announced a plan to
pre-review the appropriateness of percutaneous coronary
intervention (PCI), before payment, without explicitly
articulating the methodology with which it will make
such determinations (8).
In 2009, the ACC released the AUC for coronary
revascularization (9), and in 2011, it reported current rates
of appropriateness in the National Cardiovascular Disease
Registry (10). Although, overall, the rates of inappropriate
PCI were only 4.1%, virtually all patients undergoing PCI
in the setting of an acute coronary syndrome were appro-
priate. By contrast, 11.6% of non-acute, elective PCIs were
classified as inappropriate by the AUC, with wide variation
in the rates of inappropriate non-acute PCI across hospitals
(0% to 50%). In this issue of the Journal, Hannan et al.
(11) leveraged a detailed procedural database of all New
York hospitals doing PCI or coronary artery bypass grafting
and found similar results, although they extended the
previous report to note that very few inappropriate coronary
artery bypass grafting procedures were performed. Collec-
tively, these studies clarify that the vast majority of revas-
cularization procedures are performed in patients who have
a likelihood of benefiting from the procedure. However, as
a profession that continually strives to improve, we must
recognize that there are opportunities to further improve
patient selection for PCI. How we respond to this infor-
mation will define our field and can potentially enable us to
serve as a role model for the rest of medicine.
Before changing our pattern of patient selection, how-
ever, there needs to be general acceptance of a common
foundation with which to judge procedural appropriateness.
Informally, we have heard numerous complaints about the
AUC, which are summarized in Table 1. Although the first
fractio
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certainly improve, as new evidence and experience with their
use evolves, we contend that these critiques pale when
weighed against the benefits of systematically examining the
decision to perform coronary revascularization. More de-
tailed perspectives on some of these concerns include:
1. A large number of cases cannot be classified by the AUC,
because either a stress test was not available in the
medical record (50% of unclassifiable cases, 8.5% of all
PCIs in the National Cardiovascular Data Registry) or
the magnitude of ischemic risk was not communicated
(42% of unclassifiable cases, 7.2% overall). This is a
problem that transcends the AUC and mandates a
reformation in the way that clinicians report and ex-
change information so that the interventional cardiolo-
gist has access to all relevant information when selecting
the optimal therapy for patients. Furthermore, improv-
ing the completeness of stress test reports—including
clear definitions of minimal, moderate, and severe isch-
emic risk–has been identified as an important opportu-
nity to improve care and quality (12).
2. Concerns that a small pool (n  17) of individuals rated
the clinical indications for appropriateness in the AUC.
As a specific example, some have complained that the
rating of “inappropriate” for a patient with Canadian
Cardiovascular Society Classification II angina and low-
risk ischemia is unwarranted, although there have been
no studies to show that patients live longer after revas-
cularization than a trial of medical therapy, suggesting
little harm in waiting to see whether medications alone
can eliminate patient angina (13,14). Moreover, a survey
Commonly Cited Concerns With the AUCTable 1 Commonly Cited Concerns With the AUC
Problem Cause
Miscoding of data in NCDR Poor documentation
Perception that a small group of “experts”
defined the AUC and disagreement on
the ratings of some scenarios
Impracticality of having all cardi
and participate in the process
“Gaming” of angina severity Inter-rater reliability for the CCS
by clinicians rather than patie
Patient preferences not represented Not reliably documented or quan
Stress test results not done Physician judgment
Stress test results not interpretable Variable interpretation of finding
Stress test results not known Poor transition from outpatient
Confusion on interpretation of
AUC categories
Uncertain sounds bad
Resentment by clinicians of being
“judged”
Need to ensure value in healthc
of inexplicable excess of trea
profession
AUC  Appropriate Use Criteria; CCSC  Canadian Cardiovascular Society Classification; FFR 
ntervention.of an additional 85 practicing cardiologists from 10institutions found strong concordance (84%) between
these practitioners with the AUC expert panel, even
though the practicing clinicians, unlike the technical
panel of the AUC, did not have the opportunity to
discuss and re-rate indications with discrepant scores; a
process that would have further improved agreement
(15). Importantly, there was marked variability across
practitioners, highlighting the need for the AUC to
create a benchmark against which individual doctors can
calibrate their perceptions about the benefits of revascu-
larization.
3. Severity of angina has a huge impact on the strength of
the appropriateness of a procedure. We recognize that
the Canadian Cardiovascular Society Classification has
poor inter-rater reliability (16) because it assesses symp-
toms from the perspectives of clinicians rather than those
of patients and can be manipulated to improve the AUC
rating of a patient. Therefore, we propose that patient-
reported questionnaires, such as the Seattle Angina
Questionnaire (17,18) (which is not only reproducible
and sensitive to clinical change but also the strongest
predictor of quality of life benefits from PCI) (19), be
considered in the future to eliminate this concern.
4. Confusion with regard to the interpretation of uncertain
and inappropriate categories. To reiterate the original
document (9), a rating of “uncertain” reflects that there is
limited evidence to clearly define whether or not coro-
nary revascularization provides benefit in excess of risks
and that coronary revascularization might still confer
clinical benefit. In contrast, an inappropriate rating
suggests that, in most circumstances, there is no clear
Solution
Improved documentation
s devote the time None needed. The evidence supporting the benefits
of revascularization should be transparent to all.
Moreover, strong concordance was observed between
practicing cardiologists and the Expert Panel.
or and interpreted Use of patient-reported outcomes measures, such as
the Seattle Angina Questionnaire
e Physicians can document these to support doing
PCIs in patients rated as inappropriate
Intraprocedural documentation of ischemia (FFR)
risk Develop clear institutional procedures for
reproducibly classifying magnitude of ischemia
and risk
tient setting Improve
Communication, education, and clarification of the
categories, including that all sites are likely to
have some inappropriate procedures due to
limitations in clinical scenarios
d documented cases
demeans the
As a profession, we need to reframe our
conceptualization of the AUC from that of a
“judgment” to an opportunity to improve
nal flow reserve; NCDR  National Cardiovascular Data Registry; PCI  percutaneous coronaryologist
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can result in similar long-term outcomes without the upfront
procedural risks (20,21) and costs. Due to the limited criteria
used to create patient scenarios, there are certain to be
patients rated as inappropriate for which almost all
competent cardiologists would recommend intervention.
In these cases, the operator should very clearly document
the extenuating circumstances that warranted revascular-
ization. Nevertheless, it is unlikely that the proportion of
inappropriate cases justified by “extenuating circum-
stances” would vary so substantially across hospitals as to
explain the observed hospital variability in rates of
inappropriate non-acute PCIs. Thus, the presence of
inappropriate revascularization cases suggests that there
is room for improvement in clinical decision-making for
coronary revascularization.
Despite the potential limitations of the AUC, we believe
hat what will define our professionalism is how we react to
he AUC. Although some might advocate for their retire-
ent, this presumes that clinicians are already perfect in
heir judgment and do not have an opportunity to improve.
his is not a reasonable argument, particularly given the
xtraordinary variability observed in clinical practice (22).
ather, we should implement strategies to proactively use
he AUC to improve practice. For example, several groups
ave developed strategies to prospectively map patients to the
UC after angiography and before revascularization. Doing so
an support decision-making. Moreover, policies can be im-
lemented to obtain “second opinions” before performing
evascularization in a patient rated as inappropriate, so that a
olleague can attest to the extenuating circumstances warrant-
ng treatment in that individual. Other strategies, such as
eekly “cath conferences” that address appropriateness, is
nother promising strategy to increase consistency within a
ractice and decrease inter-operator variation.
If we can implement and improve the AUC among those
ndergoing revascularization, we will support better
ecision-making and decrease overuse of this procedure.
nce done, we will then need to develop strategies to
ddress underuse (23). There is evidence of substantial
ariability in symptom control of patients among outpa-
ients not referred for PCI. For example, a recent study of
rimary care practices throughout Australia documented
xtraordinary variability in the proportion of patients at the
ractice of each doctor who were experiencing angina
eekly or more often (24). Understanding and identifying
pportunities to offer more aggressive symptom relief to
hese patients might markedly improve their quality of life
nd confer much greater benefit than treating patients with
nappropriate indications who happen to make it to the
atheterization lab. The truth is that we might be doing
xactly the right number of revascularization procedures in
his country—we just have to be sure that we are doing them
n the right patients. The AUC are an important first step
n addressing this issue.Reprint requests and correspondence: Dr. John Spertus, Mid
America Heart Institute, 4401 Wornall Road, 5th Floor, Kansas
City, Missouri 64111. E-mail: spertusj@umkc.edu.
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